Immune Response Molecular Biology Production 
DrugBank
MAY 15, 2024
But as molecular biology has advanced, so too has our approach to finding new drugs. Another promising avenue is the use of technologies like RNA interference and gene editing, which allow scientists to turn off the production of certain proteins altogether. This method was more about serendipity than science.
Drug Target Review
DECEMBER 7, 2023
Phage have been of interest to scientists as tools to understand fundamental molecular biology, as vectors of horizontal gene transfer and drivers of bacterial evolution, as sources of diagnostic and genetic tools, and as novel therapeutic agents. In bacteria , cGAS-like cyclases are central parts of the CBASS immune response.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
LifeSciVC
JULY 1, 2024
The central dogma of molecular biology is that information generally (with few exceptions) flows from DNA to RNA to Protein. Try to create your own version of this heterodimer that synergistically brings your scientific interests together with a sense of societal responsibility. Build your social immunity.
Dark Matter Blog
JULY 16, 2021
The only subject in school that held my interest was biology. As soon as I learned about DNA and RNA, I wanted to be a molecular biologist. I wanted to use molecular biology to create drugs. 49 years ago, when I was 16 years old, I wanted to do exactly what I am doing now.
The Pharma Data
JANUARY 4, 2021
Chimeric PD-1 T-cells also release cytokines to further initiate immune responses to eradicate the tumor cells. is a preclinical stage biopharmaceutical company which is focused on discovering, developing, and commercializing novel immune-oncology applications through its robust product pipeline. Kiromic BioPharma, Inc.
Broad Institute
AUGUST 7, 2023
When STING detects that danger signal, it can turn on at least three different pathways — one leading to interferon production, one to non-canonical autophagy (involved in recycling cell components and clearing pathogens), and a third to formation of the inflammasome, a complex of proteins that activates inflammatory responses.
Codon
FEBRUARY 13, 2024
By 2004, over a dozen companies were working on developing phage products and therapies, in locations ranging from Baltimore to Bangalore, where ten years previously, there had been none. Phage-based products have been licensed for use as antibacterial agents in the sanitation , food production , and animal health industries.
Expert insights. Personalized for you.
98 
Let's personalize your content